22 results
DEF 14A
APGE
Apogee Therapeutics Inc.
24 Apr 24
Definitive proxy
4:15pm
” and the “2023 Fiscal Year”).
NAME AND PRINCIPAL
POSITION
YEAR
SALARY
BONUS
($)(2)
OPTIONS
($)(3)
STOCK
AWARDS
($)(4)
ALL OTHER
COMPENSATION
($)(5 … annual bonus of 55%, and participation in our employee benefit plans as in effect from time to time. Dr. Henderson’s amended and restated employment
10-K
2023 FY
APGE
Apogee Therapeutics Inc.
5 Mar 24
Annual report
6:15am
Year”).
STOCK
ALL OTHER
SALARY
BONUS
OPTIONS
AWARDS
COMPENSATION
TOTAL
NAME AND PRINCIPAL POSITION
YEAR
($)(2)
($)(3)
($)(4)
($)(5)
Michael … . Henderson is eligible to receive an annual base salary of $630,000, a target annual bonus of 55%, and participation in our employee benefit plans
DRS
APGE
Apogee Therapeutics Inc.
9 Feb 24
Draft registration statement
12:00am
rendered during the years ended December 31, 2022 and 2023 (the 2022 and 2023 Fiscal Years).
NAME AND PRINCIPAL POSITION
YEAR
SALARY
BONUS
($)(2)
OPTIONS … is eligible to receive an annual base salary of $630,000, a target annual bonus of 55%, and participation in our employee benefit plans as in effect from
10-Q
2023 Q2
EX-10.2
APGE
Apogee Therapeutics Inc.
28 Aug 23
Quarterly report
8:00am
in Control Period), (i) a material diminution in Executive’s base salary or target bonus except for across-the-board salary and target bonus reductions … as may be assigned from time to time.
2.2.Annual Bonus. For each calendar year ending during the Term, Executive shall be eligible to receive an annual
10-Q
EX-10.9
sler2qya c2n
28 Aug 23
Quarterly report
8:00am
10-Q
EX-10.3
wn2dpvj
28 Aug 23
Quarterly report
8:00am
10-Q
EX-10.4
2esm9 x60ihh4
28 Aug 23
Quarterly report
8:00am
10-Q
0c14e
28 Aug 23
Quarterly report
8:00am
424B4
0xietf q1unl3dk
17 Jul 23
Prospectus supplement with pricing info
4:08pm
S-1
EX-10.3
q9dtiy6fp x9tvsnv
22 Jun 23
IPO registration
4:19pm
S-1
EX-10.4
7wcym
22 Jun 23
IPO registration
4:19pm
S-1
kicnjsksoer
22 Jun 23
IPO registration
4:19pm
S-1
EX-10.2
rt8oxe9o
22 Jun 23
IPO registration
4:19pm
DRS/A
ugng lhtw
5 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
EX-10.4
3aojscpfw
5 Jun 23
Draft registration statement (amended)
12:00am